Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(9 sites)

United States

Trinitas Hospital and Comprehensive Cancer Center, Elizabeth, New Jersey

RWJBarnabas Health Jersey City Medical Center, Jersey City, New Jersey

RWJBarnabas Health - Monmouth Medical Center Southern Campus, Lakewood, New Jersey

Cooperman Barnabas Medical Center (Saint Barnabas Medical Center), Livingston, New Jersey

RWJBarnabas Health - Monmouth Medical Center, Long Branch, New Jersey

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey

RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Jersey

RWJBarnabas Health - Robert Wood Johnson University Hospital, Somerset, New Jersey

RWJBarnabas Health - Community Medical Center, Toms River, New Jersey